Lamivudine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 100 mg, 150 mg, 300 mg

Reference Brands: Epivir®, Epivir-HBV® (US & EU)

Category: Hepatitis

Lamivudine Tablets are oral antiviral medications used to manage chronic Hepatitis B infection. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine reduces viral replication and liver inflammation. Commonly available in 100 mg strength for Hepatitis B treatment, it is approved by regulatory authorities in the EU and US. Suitable for inclusion in pharma B2B supply chains, Lamivudine is trusted for its safety, efficacy, and global therapeutic relevance. Lamivudine is available in Tablet and strengths such as 100 mg, 150 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lamivudine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Lamivudine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Lamivudine Tablets are antiviral medications primarily used to treat chronic Hepatitis B virus (HBV) infection and HIV-1 as part of combination therapy. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine effectively suppresses viral replication, reducing liver inflammation and disease progression. Available in 100 mg tablets for hepatitis B and 150–300 mg for HIV, it is widely prescribed and globally trusted. Manufactured under stringent EU-GMP and USFDA standards, Lamivudine is an essential product in hospital procurement and pharma B2B export portfolios. Its proven safety, cost-effectiveness, and global demand make it a key antiviral in the EU and US healthcare markets.